Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms

Wound Repair and Regeneration

Volumn 19, Issue 1, 2011, Pages 1-9

  Percival, Steven L ^a,b   Hill, Katja E ^c   Malic, Sladjana ^c   Thomas, David W ^c   Williams, David W ^c  

^a Advanced Medical Solutions   (United Kingdom)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; FLUCLOXACILLIN; POVIDONE IODINE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; BIOFILM; CHRONIC DISEASE; FLUORESCENCE IN SITU HYBRIDIZATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH RATE; LEG ULCER; MICROCOCCUS LUTEUS; MICROFLORA; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS ORALIS; WOUND HEALING; WOUND INFECTION;

BIOFILMS; DRUG RESISTANCE, BACTERIAL; HUMANS; WOUND INFECTION;

EID: 78751545483     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2010.00651.x     Document Type: Article

References (106)

1. Gottrup F., A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg 2004; 187: 38S-43S.
2. Brem H, Stojadinovic O, Diegelmann RF, Entero H, Lee B, Pastar I, Golinko M, Rosenberg H, Tomic-Canic M., Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med 2007; 13: 30-9.
3. Davies CE, Hill KE, Newcombe RG, Stephens P, Wilson MJ, Harding KG, Thomas DW., A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs. Wound Rep Regen 2007; 15: 17-22.
4. Trengove NJ, Stacey MC, McGechie DF, Mata S., Qualitative bacteriology and leg ulcer healing. J Wound Care 1996; 5: 277-80.
5. Hansson C, Hoborn J, Möller A, Swanbeck G., The microbial flora in venous leg ulcers without clinical signs of infection. Acta Dermatol Venereol 1995; 75: 24-30.
6. Schmidt K, Debus ES, Jessberger S, Ziegler U, Thiede A., Bacterial population of chronic crural ulcers: is there a difference between the diabetic, the venous, and the arterial ulcer? VASA 2000; 29: 62-70.
7. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, Wolcott RD., Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008; 8: 43.
8. Frank DN, Wysocki A, Specht-Glick DD, Rooney A, Feldman RA, St Amand AL, Pace NR, Trent JD., Microbial diversity in chronic open wounds. Wound Repair Regen 2009; 2: 163-72.
9. Price LB, Liu CM, Melendez JH, Frankel YM, Engelthaler D, Aziz M, Bowers J, Rattray R, Ravel J, Kingsley C, Keim PS, Lazarus GS, Zenilman JM., Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. PLoS One 2009; 7: e6462.
10. Martin JM, Zenilman JM, Lazarus GS., Molecular microbiology: new dimensions for cutaneous biology and wound healing. J Invest Dermatol 2010; 1: 38-48.
11. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D., Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 2008; 3: e3326.
12. Davies CE, Hill KE, Wilson MJ, Stephens P, Hill CM, Harding KG, Thomas DW., Use of 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis for analysis of the microfloras of healing and non-healing chronic venous leg ulcers. J Clin Microbiol 2004; 42: 3549-57.
13. Thomsen TR, Aasholm MS, Rudkjobing VB, Saunders AM, Bjarnsholt T, Givskov M, Kirketerp-Moller K, Nielsen PH., The bacteriology of chronic venous leg ulcer examined by culture-independent molecular methods. Wound Rep Regen 2010; 18: 38-49.
14. Percival SL, Thomas J, Williams D., An introduction to the world of microbiology and biofilmology. Vol. 1. In:, Percival SL, Cutting K, editors. Microbiology of wounds. New York: CRC Press, 2010: 1-58.
15. Percival SL, Beech IB, Knapp JS, Wales DS, Edyvean RGJ., Biofilm development on 304 and 316 stainless steels in a potable water system. Water Environ Manage J 1997; 11: 289-94.
16. Percival SL, Knapp JS, Wales DS, Edyvean RGJ., Biofilm development in mains water. Water Res 1998; 32: 243-53.
17. Hall-Stoodley L, Costerton JW, Stoodley P., Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004; 2: 95-108.
18. Kite P, Eastwood K, Sugden S, Percival SL., Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 2004; 42: 3073-6.
19. Percival SL, Kite P, Donlan R., Assessing the effectiveness of tetrasodium ethylenediaminetetraacetic acid as a novel central venous catheter (CVC) lock solution against biofilms using a laboratory model system. Infect Control Hosp Epidemiol 2005; 26: 515-9.
20. Clutterbuck AL, Cochrane CA, Dolman J, Percival SL., Evaluating antibiotics for use in medicine using a poloxamer biofilm model. Ann Clin Microbiol Antimicrob 2007; 6: 2.
21. Stewart PS, Costerton JW., Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135-8.
22. Licking E., Getting a grip on bacterial slime. Business Week 1999; 13: 98-100.
23. Archibald LK, Gaynes RP., Hospital acquired infections in the United States: the importance of interhospital comparisons. Nosocomial Infect 1997; 11: 245-55.
24. Potera C., Forging a link between biofilms and disease. Science 1999; 283: 1837-8.
25. Percival SL, Bowler P., Biofilms and their potential role in wound healing. Wounds 2004; 16: 234-40.
26. Percival SL, Rogers AA,. The significance and role of biofilms in chronic wounds. In:, McBain A, Allison D, Pratten J, Spratt D, Upton M, Verran J, editors. Biofilms: persistence and ubiquity. Cardiff: BioLine, 2005: 171-9.
27. Percival SL, Bowler PG, Dolman J., Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J 2007; 4: 186-91.
28. Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM., A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualised by light microscopy. Dermatol Surg 2003; 29: 631-5.
29. Mertz PM., Cutaneous biofilm: friend or foe? Wounds 2003; 15: 129-32.
30. Malic S, Hill KE, Hayes A, Percival SL, Thomas DW, Williams DW., Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid (PNA) fluorescent in situ hybridisation (FISH). Microbiology 2009; 155: 2603-11.
31. Bjarnsholt T, Kirkterp-Màller K, Jensen Pà Madsen KG, Phipps R, Krogfelt K, Hàiby N, Givskov M., Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008; 16: 2-10.
32. Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM., Microscopic and physiologic evidence for biofilm-associated wound colonisation in vivo. Wound Repair Regen 2008; 16: 23-9.
33. Rhoads DD, Wolcott RW, Cutting KF, Percival SL., Evidence of biofilms in wounds and potential ramifications. In:, Gilbert P, Allison D, Brading M, Pratten J, Spratt D, Upton M, editors. Biofilms: coming of age. Manchester: BioLine, 2007: 131-43.
34. Thomas J, Percival SL., Bacterial synergy: a common theme linking infections in chronic wounds and endotracheal tubes/ventilator-associated pneumonia. In:, Gilbert P, Allison D, Brading M, Pratten J, Spratt D, Upton M, editors. Biofilms: coming of age. Manchester: BioLine, 2007: 79-86.
35. Wolcott RD, Rhoads DD., A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 2008; 17: 145-8.
36. Ofek I, Beachey EH., General concepts and principals of bacterial adherence in animals and man. In:, Beachey EH, editor. Bacterial adherence. Receptors & recognition. London: Chapman & Hall, 1980: 1-29.
37. Woods EJ, Davis P, Barnett J, Percival SL., Wound healing immunology and biofilms. Vol. 10. In:, Percival S, Cutting K, editors. Microbiology of wounds. New York: CRC Press, 2010: 271-92.
38. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI., Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nature Immunol 2002; 3: 354-9.
39. Hoyle BD, Costerton JW., Bacterial resistance to antibiotics: the role of biofilms. Prog Drug Res 1991; 37: 91-105.
40. Rhoads D, Walcott R, Percival SL., Management of biofilms in chronic wounds. J Wound Care 2008; 17: 502-8.
41. Cos P, Toté K, Horemans T, Maes L., Biofilms: an extra hurdle for effective antimicrobial therapy. Curr Pharm Des 2010; 16: 2279-95.
42. Lewis K., Persister cells, dormancy and infectious disease. Nature Rev Microbiol 2007; 5: 48-56.
43. Landini P, Antoniani D, Burgess JG, Nijland R., Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal. Appl Microbiol Biotechnol 2010; 86: 813-23.
44. Walsh C., Molecular mechanisms that confer antibacterial drug resistance. Nature 2000; 406: 775-81.
45. Hàiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O., Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010; 35: 322-32.
46. Xu KD, McFeters GA, Stewart PS., Biofilm resistance to antimicrobial agents. Microbiology 2000; 146: 547-9.
47. Davies D., Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2003; 2: 114-22.
48. Spoering AL, Lewis K., Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 2001; 183: 6746-51.
49. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ., Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987; 41: 435-64.
50. Gordon CA, Hodges NA, C Marriott C., Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. J Antimicrob Chemother 1988; 22: 667-74.
51. Kumon H, Tomochika K, Matunaga T, Ogawa M, Ohmori H., A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides. Microbiol Immunol 1994; 38: 615-9.
52. Shigeta M, Tanaka G, Komatsuzawa H, Sugai M, Suginaka H, Usui T., Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. Chemotherapy 1997; 43: 340-5. (Pubitemid 27346061)
53. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA., A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003; 426: 306-10.
54. Stewart PS, Roe F, Rayner J, Elkins JG, Lewandowski Z, Ochsner UA, Hassett DJ., Effect of catalase on hydrogen peroxide penetration into Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2000; 66: 836-8.
55. Sanderson SS, Stewart PS., Evidence of bacterial adaptation to monochloramines in Pseudomonas aeruginosa biofilms and evaluation of biocide action model. Biotechnol Bioeng 1997; 56: 201-9.
56. Hassett DJ, Ma JF, Elkins JG, McDermott TR, Ochsner UA, West SEH, Huang CT, Fredericks J, Burnett S, Stewart PS, McFeters G, Passador L, Iglewski BH., Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol Microbiol 1999; 34: 1082-93.
57. Elkins JG, Hassett DJ, Stewart PS, Schweizer HP, McDermott TR., Protective role of catalase in Pseudomonas aeruginosa biofilm resistance to hydrogen peroxide. Appl Environ Microbiol 1999; 65: 4594-600.
58. Anderl JN, Franklin MJ, Stewart PS., Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000; 44: 1818-24.
59. Stewart PS., Diffusion in biofilms. J Bacteriol 2003; 185: 1485-91.
60. Tuomanen E, Cozens R, Tosch W, Zak O, Tomasz A., The rate of killing of Escherichia coli by β-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol 1986; 132: 1297-304.
61. Walters MC III, Roe F, Bugnicourt A, Franklin MJ, Stewart PS., Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003; 47: 317-23.
62. Brown MR, Allison DG, Gilbert P., Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother 1988; 22: 777-80.
63. Sufya N, Allison DG, Gilbert P., Clonal variation in maximum specific growth rate and susceptibility towards antimicrobials. J Appl Microbiol 2003; 95: 1261-7.
64. Borriello G, Werner E, Roe F, Kim AM, Ehrlich GD, Stewart PS., Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 2004; 48: 2659-64.
65. Zhang XS, García-Contreras R, Wood TK., (YcfR (BhsA) influences Escherichia coli biofilm formation through stress response and surface hydrophobicity. J Bacteriol 2007; 189: 3051-62.
66. Gilbert P, Collier PJ, Brown MR., Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob Agents Chemother 1990; 34: 1865-8. (Pubitemid 20290280)
67. Gilbert P, Allison DG, Rickard A, Whyte FW, McBain AJ., Do biofilms present a nidus for the evolution of antibacterial resistance? In:, Gilbert P, Allison D, Brading M, Verran J, Walker J, editors. Biofilms community interactions: chance or necessity. Cardiff: BioLine, 2001: 341-51.
68. Gilbert P, Das J, Foley I., Biofilm susceptibility to antimicrobials. Adv Dent Res 1997; 11: 160-7.
69. de Beer D, Stoodley P, Roe F, Lewandowski Z., Effects of biofilm structure on oxygen distribution and mass transport. Biotechnol Bioeng 1994; 43: 1131-8.
70. Zhang TC, Bishop PL., Evaluation of substrate and pH effects in a nitrifying biofilm. Water Environ Res 1996; 68: 1107-15.
71. Tack KJ, Sabath LD., Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin. Chemotherapy 1985; 31: 204-10.
72. Prigent-Combaret C, Vidal O, Dorel C, Lejeune P., Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. J Bacteriol 1999; 181: 5993-6002.
73. Das JR, M Bhakoo M, Jones MV, Gilbert P., Changes in the biocide susceptibility of Staphylococcus epidermidis and Escherichia coli cells associated with rapid attachment to plastic surfaces. J Appl Microbiol 1998; 84: 852-8.
74. Cochran WL, McFeters GA, Stewart PS., Reduced susceptibility of thin Pseudomonas aeruginosa biofilms to hydrogen peroxide and monochloramine. J Appl Microbiol 2000; 88: 22-30.
75. Brooun A, Liu S, Lewis K., A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2000; 44: 640-6.
76. Goto T, Nakame Y, Nishida M, Ohi Y., In vitro bactericidal activities of beta-lactamases, amikacin, and fluoroquinolones against Pseudomonas aeruginosa biofilm in artificial urine. Urology 1999; 53: 1058-62.
77. Yasuda H, Ajiki Y, Koga T, Kawada H, Yokota T., Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother 1993; 37: 1749-55.
78. Williams I, Venables WA, Lloyd D, Paul F, Critchley I., The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus. Microbiology 1997; 143: 2407-13.
79. Parsek MR, Greenberg EP., Acyl-homoserine lactone quorum sensing in gram-negative bacteria: a signaling mechanism involved in associations with higher organisms. Proc Natl Acad Sci USA 2000; 97: 8789-93.
80. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K., Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 2004; 230: 13-8.
81. Harrison JJ, Turner RJ, Ceri H., Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa. Environ Microbiol 2005; 7: 981-94.
82. Bigger JW., Treatment of staphylococcal infections with penicillin-by intermittent sterilisation. Lancet 1944; 2: 497-500.
83. Lewis K., Riddle of biofilm resistance. Antimicrob Agents Chemother 2001; 45: 999-1007.
84. Stewart PS, Franklin MJ., Physiological heterogeneity in biofilms. Nat Rev Microbiol 2008; 6: 199-210.
85. Lewis K., Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 2008; 322: 107-31.
86. Harrison JJ, Wade WD, Akierman S, Vacchi-Suzzi C, Stremick CA, Turner RJ, Ceri H., The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob Agents Chemother 2009; 53: 2253-8.
87. Black DS, Kelly AJ, Mardis MJ, Moyed HS., Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J Bacteriol 1991; 173: 5732-9.
88. Keren I, Kaldalu N, Spoering A, Wang YP, Lewis K., Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 2004; 186: 8172-80.
89. Kim Y, Wood TK., Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in Escherichia coli. Biochem Biophys Res Commun 2010; 391: 209-13.
90. Christensen SK, Mikkelsen M, Pedersen K, Gerdes K., RelE, a global inhibitor of translation, is activated during nutritional stress. Proc Natl Acad Sci USA 2001; 98: 14328-33.
91. Dörr T, Vulic M, Lewis K., Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 2010; 8: e1000317.
92. Ma C, Sim SZ, Shi WL, Du LJ, Xing DM, Zhang Y., Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli. FEMS Microbiol Lett 2010; 303: 33-40.
93. Spoering AL, VuliÄ M, Lewis K., GlpD and PlsB participate in persister cell formation in Escherichia coli. J Bacteriol 2006; 188: 5136-44.
94. Vazquez-Laslop N, Lee H, Neyfakh AA., Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J Bacteriol 2006; 188: 3494-7.
95. Li YF, Zhang Y., PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob Agents Chemother 2007; 51: 2092-9.
96. Korch SB, Henderson TA, Hill TM., Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p) ppGpp synthesis. Mol Microbiol 2003; 50: 1199-213.
97. Singh R, Ray P, Das A, Sharma M., Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J Med Microbiol 2009; 58: 1067-73.
98. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A., The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 1771-6.
99. Hill KE, Malic S, McKee R, Rennison T, Harding KG, Williams DW, Thomas DW., An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J Antimicrob Chemother 2010; 65: 1195-206.
100. Trafny EA., Susceptibility of adherent organisms from Pseudomonas aeruginosa and Staphylococcus aureus strains isolated from burn wounds to antimicrobial agents. Int J Antimicrob Agents 1998; 10: 223-38.
101. Smith AL, Fiel SB, Mayer-Hamblett N, Ramsey B, Burns JL., Lack of association between in vitro antibiotic susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parental antibiotic administration in cystic fibrosis. Chest 2003; 123: 1495-502.
102. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM., Microbial biofilms. Annu Rev Microbiol 1995; 49: 711-45.
103. Moskowitz SM, Foster JM, Emerson J, Burns JL., Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004; 42: 1915-22.
104. Howell-Jones RS, Wilson MJ, Hill KE, Howard AJ, Price PE, Thomas DW., A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 2005; 55: 143-9.
105. Percival SL, Cooper R, Lipsky B., Antimicrobial interventions for wounds. Vol. 11. In:, Percival S, Cutting K, editors. Microbiology of wounds. New York: CRC Press, 2010: 293-328.
106. Percival SL, Thomas JG, Williams DW., Biofilms and bacterial imbalances in chronic wounds: anti-Koch. Int Wound J 2010; 7: 169-75.